Sunitinib Capsule

Available Composition of

Sunitinib Capsule
NameStrengthTherapeutic useView More
Sunitinib Capsule25 mg, 50 mg

Product Description For Sunitinib Capsule

products details and uses

Sunitinib Exporter India, Manufacturer, Wholesaler & Distributor

Sunitinib Capsules are a targeted cancer therapy used in the treatment of advanced renal cell carcinoma (kidney cancer) and gastrointestinal stromal tumors (GIST). This medication works by inhibiting specific tyrosine kinase enzymes that promote cancer cell growth and the formation of blood vessels that supply tumors. By blocking these enzymes, Sunitinib helps shrink tumors and slow disease progression.

  • Manufacturing: GMP-compliant production facilities ensure consistent quality and safety.

  • Exporting: Indian exporters supply Sunitinib Capsules to regulated and semi-regulated markets worldwide, meeting international documentation and compliance requirements.

  • Wholesaling & Distribution: A robust network of authorized wholesalers and distributors ensures timely availability of Sunitinib across hospitals, pharmacies, and cancer treatment centers in India and abroad.

  • Global Distribution Network

    With a strong logistics and compliance framework, we successfully export Sunitinib to a broad range of international markets, including: Venezuela, Brazil, Cambodia, Philippines, Nigeria, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan, Kenya, Zimbabwe, Somalia, Djibouti, Belarus, Macedonian, And Turkey.